Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
Ephraim S. Casper(Memorial Sloan Kettering Cancer Center), Mark R. Green(University of California, San Diego), David P. Kelsen(Memorial Sloan Kettering Cancer Center), Robert T. Heelan(Memorial Sloan Kettering Cancer Center), Thomas D. Brown(The University of Texas at Austin), Carlos D. Flombaum(Memorial Sloan Kettering Cancer Center), Bonnie J. Trochanowski(Memorial Sloan Kettering Cancer Center), Peter G. Tarassoff(Eli Lilly (United States))
Cited by 441
Abstract
Related Papers
No related papers found
Powered by citation graph analysis